A multicentre, non-interventional study to evaluate long-term safety in patients with achondroplasia treated with Voxzogo® (vosoritide) (BMN 111-603)

20/10/2022
23/04/2024
EU PAS number:
EUPAS47514
Study
Ongoing
Documents
Study protocol
Study results
Study report
Other information